Abstract:Zhao et al [1] from Shanghai, China, have undertaken a detailed clinical study in a cohort of 206 asymptomatic patients with type 2 diabetes utilizing advanced in vivo nerve imaging with corneal confocal microscopy (CCM-Heidelberg HRT III RCM) and continuous glucose monitoring (CGM-iPro2 system) over 7 days. The study provides important insights into the relationship between relatively short-term glucose perturbation over 7 days and corneal nerve loss in diabetic neuropathy. Furthermore, it reinforces the role of CCM in detecting early sub-clinical nerve loss, as almost one-third of asymptomatic patients had corneal nerve fiber loss, which was independently associated with glucose time in range (TIR) (percentage of time within the glucose range of 3.9–10.0 mmol/L) but not with quartiles of hemoglobin A1c (HbA1c), an established measure of long-term glycemic control. Indeed, each 10% increase in TIR was associated with a 28.2% (95% CI: 0.595–0.866, P = 0.001) decrease in the risk of abnormal corneal nerve fiber length (CNFL). This supports recent studies showing that TIR is associated with other long-term complications of diabetes, including symptomatic diabetic neuropathy in patients with nephropathy [2] and diabetic retinopathy. [3]

Corneal confocal microscopy meets continuous glucose monitoring: a tale of two technologies